Given that p53 is the most frequently mutated gene in human cancer and plays crucial roles in regulating the cell cycle, tumor microenvironment, and cell death, including apoptosis, ferroptosis, and autophagy, developing a possible strategy composed of As2O3 and conventional anticancer drugs may provide novel insights into approaches designed to combat GBM. This evidence concerns the gene TP53 and cancer.